Literature DB >> 19843494

Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients.

Jennifer M Polinski1, Sebastian Schneeweiss, Raisa Levin, William H Shrank.   

Abstract

BACKGROUND: In the elderly (those aged >or=65 years), retail pharmacy claims are used to study drug use among the uninsured after drug policy changes, to prevent drug-drug interactions and duplication of therapy, and to guide medication therapy management. Claims include only prescriptions filled at 1 pharmacy location or within 1 pharmacy chain and do not include prescriptions filled at outside pharmacies, potentially limiting research accuracy and pharmacy-based safety interventions.
OBJECTIVES: The aims of this study were to assess elderly patients' pharmacy loyalty and to identify predictors of using multiple pharmacies.
METHODS: Patients enrolled in the Pharmaceutical Assistance Contract for the Elderly (PACE) pharmacy benefit program with corresponding Medicare claims in the state of Pennsylvania comprised the study cohort. Among patients with pharmacy claims from all pharmacies used in 2004-2005, a primary pharmacy was defined as the pharmacy where at least 50% of a patient's prescriptions were filled. The number of pharmacies/chains used and prescriptions filled in 2005 was calculated. Predictors of using multiple pharmacies in 2005 were age, female gender, white race, urban residency, comorbidities, number of distinct chemical drugs (unique medications) used, and number of prescriptions filled, which were all assessed in 2004.
RESULTS: In total, pharmacy claims data from 182,116 patients (147,718 women [81.1%]; mean [SD] age, 78.8 [7.1] years; 168,175 white [92.3%]; 76,580 [42.1%] residing in an urban zip code area) were included. Of the 182,116 PACE patients in the study, a primary pharmacy was identified for 180,751 patients (99.3%). In 2005, patients filled an average of 59.3 prescriptions, with 57.0 prescriptions (96.1%) having been filled at the primary pharmacy. Compared with patients who used <or=5 unique medications in 2004, patients who used 6 to 9 unique medications had 1.38 times (95% CI, 1.34-1.43), and patients who used >or=15 unique medications had a 2.66 times (95% CI, 2.53-2.80) greater likelihood of using multiple pharmacies in 2005. Patients aged >or=85 years were 1.07 times (95% CI, 1.04-1.11) as likely to use multiple pharmacies compared with patients aged 65 to 74 years.
CONCLUSIONS: This study found that patients aged >or=65 years were loyal to their primary pharmacy, offering reassurance to researchers and pharmacists who use retail pharmacy claims data to evaluate and/or to improve safe and appropriate medication use among the elderly. Care should be used in analyzing claims or managing the drug regimens of patients using multiple medications or patients aged >or=85 years; they are more likely to use multiple pharmacies and thus are more likely to have missing prescription information.

Entities:  

Mesh:

Year:  2009        PMID: 19843494      PMCID: PMC2780348          DOI: 10.1016/j.clinthera.2009.09.009

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  14 in total

1.  Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Authors:  S Schneeweiss; J D Seeger; M Maclure; P S Wang; J Avorn; R J Glynn
Journal:  Am J Epidemiol       Date:  2001-11-01       Impact factor: 4.897

2.  Detection of medication nonadherence through review of pharmacy claims data.

Authors:  Nella Bieszk; Rosalie Patel; Andrea Heaberlin; Ken Wlasuk; Barbara Zarowitz
Journal:  Am J Health Syst Pharm       Date:  2003-02-15       Impact factor: 2.637

3.  Prescription drug coverage and seniors: findings from a 2003 national survey.

Authors:  Dana Gelb Safran; Patricia Neuman; Cathy Schoen; Michelle S Kitchman; Ira B Wilson; Barbara Cooper; Angela Li; Hong Chang; William H Rogers
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Jun       Impact factor: 6.301

4.  The impact of Medicare Part D on prescription drug use by the elderly.

Authors:  Frank R Lichtenberg; Shawn X Sun
Journal:  Health Aff (Millwood)       Date:  2007 Nov-Dec       Impact factor: 6.301

5.  A chronic disease score from automated pharmacy data.

Authors:  M Von Korff; E H Wagner; K Saunders
Journal:  J Clin Epidemiol       Date:  1992-02       Impact factor: 6.437

6.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

Authors:  P S Romano; L L Roos; J G Jollis
Journal:  J Clin Epidemiol       Date:  1993-10       Impact factor: 6.437

7.  Prescription drugs and the elderly: issues and options.

Authors:  S H Long
Journal:  Health Aff (Millwood)       Date:  1994 Spring (II)       Impact factor: 6.301

8.  The effect of transitioning to medicare part d drug coverage in seniors dually eligible for medicare and medicaid.

Authors:  William H Shrank; Amanda R Patrick; Alex Pedan; Jennifer M Polinski; Laleh Varasteh; Raisa Levin; Nan Liu; Sebastian Schneeweiss
Journal:  J Am Geriatr Soc       Date:  2008-12       Impact factor: 5.562

9.  More nonelderly Americans face problems affording prescription drugs.

Authors:  Laurie E Felland; James D Reschovsky
Journal:  Track Rep       Date:  2009-01

10.  The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.

Authors:  Wesley Yin; Anirban Basu; James X Zhang; Atonu Rabbani; David O Meltzer; G Caleb Alexander
Journal:  Ann Intern Med       Date:  2008-01-07       Impact factor: 25.391

View more
  13 in total

1.  Evidence of sample use among new users of statins: implications for pharmacoepidemiology.

Authors:  Xiaojuan Li; Til Stürmer; M Alan Brookhart
Journal:  Med Care       Date:  2014-09       Impact factor: 2.983

2.  A systematic review of methods for determining cross-sectional active medications using pharmacy databases.

Authors:  Timothy S Anderson; Edison Xu; Evans Whitaker; Michael A Steinman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-13       Impact factor: 2.890

3.  Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources.

Authors:  Maria A P Martins; Paula P S Carlos; Daniel D Ribeiro; Vandack A Nobre; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro
Journal:  Eur J Clin Pharmacol       Date:  2011-06-24       Impact factor: 2.953

4.  Use of combination antihypertensive therapy initiation in older Americans without prevalent cardiovascular disease.

Authors:  Xiaojuan Li; Wendy Camelo Castillo; Til Stürmer; Virginia Pate; Christine L Gray; Ross J Simpson; Soko Setoguchi; Laura C Hanson; Michele Jonsson Funk
Journal:  J Am Geriatr Soc       Date:  2014-08-12       Impact factor: 5.562

Review 5.  Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review.

Authors:  Jennifer M Polinski; Elaine Kilabuk; Sebastian Schneeweiss; Troyen Brennan; William H Shrank
Journal:  J Am Geriatr Soc       Date:  2010-09       Impact factor: 5.562

6.  A four-phase approach for systematically collecting data and measuring medication discrepancies when patients transition between health care settings.

Authors:  Korey A Kennelty; Matthew J Witry; Michael Gehring; Melissa Dattalo; Nicole Rogus-Pulia
Journal:  Res Social Adm Pharm       Date:  2015-09-12

7.  Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.

Authors:  Jennifer M Polinski; M Alan Brookhart; Robert J Glynn; Sebastian Schneeweiss
Journal:  J Clin Psychopharmacol       Date:  2012-02       Impact factor: 3.153

8.  Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D.

Authors:  Zachary A Marcum; Julia Driessen; Carolyn T Thorpe; Walid F Gellad; Julie M Donohue
Journal:  J Am Geriatr Soc       Date:  2014-01-21       Impact factor: 5.562

9.  Completeness of prescription information in US commercial claims databases.

Authors:  Julie C Lauffenburger; Akhila Balasubramanian; Joel F Farley; Cathy W Critchlow; Cynthia D O'Malley; Mary T Roth; Virginia Pate; M Alan Brookhart
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-05-21       Impact factor: 2.890

10.  Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.

Authors:  Nathan J Pauly; Jeffery C Talbert; Joshua Brown
Journal:  J Manag Care Spec Pharm       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.